BackIgene Biotechnology Overview

Igene Biotechnology Accounts Payable

Igene Biotechnology's accounts payable is $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer trimmed avg / median

Loading

Igene Biotechnology Accounts Payable History

Loading

Igene Biotechnology vs. peers: Accounts Payable Comparison

Loading

Igene Biotechnology Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Igene Biotechnology (IGNE) FAQ

The latest accounts payable for IGNE is $0 as of September 2010. In the prior-year period, the figure was $0. Investors often review this figure alongside Igene Biotechnology's historical trend and sector peers before judging valuation or financial health.

Over the past year, IGNE's accounts payable moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Igene Biotechnology's operating scale or balance-sheet position.

A accounts payable figure of $0 for IGNE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IGNE's accounts payable ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers